Role of insulin-like growth factor binding protein-4 in prevention of colon cancer
2007

Role of IGFBP-4 in Preventing Colon Cancer

Sample size: 18 publication 10 minutes Evidence: moderate

Author Information

Author(s): Durai Rajaraman, Yang Shi, Seifalian Alexander, Goldspink Geoffrey, Winslet Marc C

Primary Institution: University College London

Hypothesis

Does insulin-like growth factor binding protein-4 (IGFBP-4) prevent the development of colon cancer?

Conclusion

IGFBP-4 gene therapy did not prevent colon cancer initiation but increased apoptosis and decreased tumor cell division.

Supporting Evidence

  • IGFBP-4 gene therapy did not prevent tumor establishment.
  • Tumor apoptosis increased in the IGFBP-4 treated group.
  • Bax protein expression was higher in tumors treated with IGFBP-4.
  • Tumor volume and weight were similar across treatment groups.

Takeaway

The study tested if a protein could stop colon cancer from starting, but it didn't work; however, it did help more cancer cells die.

Methodology

Nude mice were injected with colon cancer cells and treated with IGFBP-4 gene therapy, then assessed for tumor characteristics after four weeks.

Limitations

The study did not assess long-term outcomes or survival rates of the mice.

Participant Demographics

MF1 nu/nu male athymic mice, aged 4-6 weeks.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-7819-5-128

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication